1 Disclaimer General. This presentation (this "Presentation") is provided solely for informational purposes. This Presentation is subject to update, completion, revision, verification and further amendment without notice. None of Abacus Global Management, Inc. (the "Company", "Abacus", Abacus Global Management", "we", "our", or "us") or its affiliates has authorized anyone to provide interested parties with additional or different information. The information contained herein does not purport to be all incl ...

Financial Performance - Q3 2025 - Gross revenue reached $63 million, a 124% increase year-over-year compared to $2814 million in Q3 2024[21, 72] - Adjusted Net Income was $236 million, up from $147 million in the prior-year period[21, 72] - Adjusted EBITDA increased to $379 million, compared to $167 million in the prior-year period[21, 72] - Capital deployed for policy purchases totaled $1024 million[21] - Assets Under Management (AUM) reached $33 billion[16, 21] Growth & Profitability - Year-over-year revenue growth was 124%[22] - Year-over-year growth in capital deployed was 10%[22] - Adjusted Annualized Return on Equity (ROE) was 22%[22] - Adjusted Annualized Return on Invested Capital (ROIC) was 21%[20, 22] - Adjusted EBITDA Margin was 60%[20, 22] Revenue Mix & Targets - Life Solutions contributed 84% of revenue year-to-date, with a 5-year target of 30%[24] - Asset Group contributed 15% of revenue year-to-date, with a 5-year target of 30%[20, 24] - Technology contributed less than 1% of revenue year-to-date, with a 5-year target of 10%[24] - Wealth Advisors had no revenue year-to-date, with a 5-year target of 30%[24] Abacus Asset Group - Capital inflows for the quarter were $713 million, bringing the year-to-date total to $3544 million[25, 50] - Management fees for the quarter were $86 million, with a year-to-date total of $219 million[25, 50] - The company is targeting over $4 billion in fee-paying AUM by the end of 2026[25] ABL Tech - ABL Tech is tracking over 26 million lives[25, 62] - ABL Tech experienced a 21x year-over-year increase in lives tracked[25, 60]

Financial Performance - Q2 2025 - Total revenue nearly doubled, reaching $56.2 million compared to $29.1 million in the prior-year period, representing a 93% increase[54] - Adjusted Net Income increased to $21.9 million, compared to $11.7 million, and Adjusted EBITDA increased to $31.5 million, compared to $16.7 million in the prior-year period[54] - GAAP Net Income attributable to shareholders was $17.6 million, compared to $0.7 million in the prior-year period[54] - Assets Under Management (AUM) reached $3.3 billion[17,56] Growth & Capital Deployment - Capital deployed for policy purchases in Q2 2025 amounted to $121.8 million[31,56] - Longevity Funds attracted $123.1 million in capital inflows for the quarter, with the ETFs seeing a +9% increase in growth in AUM compared to the prior quarter[54] - Year-over-year growth in capital deployed totaled $142 million, representing a 16% increase[19] ABL Tech - Mortality Tracking - ABL Tech's mortality tracking system now covers 2,033,198 lives in Q2 2025[46] - ABL Tech experienced a 17x year-over-year increase in lives tracked[44] FY 2025 Guidance - The company raised its Adjusted Net Income guidance for FY 2025 to a range of $74 million to $80 million, implying a +59% to +72% year-over-year change[58]